Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy

Published on: 10 June, 2020

Cook G, Ashcroft AJ, Pratt G, et al. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy. Br J Haematol. 2020 Jul;190(2):e83-e86. Epub 2020 Jun 10.

doi.org/10.1111/bjh.16874

Related Themes

Related Team Members

Professor Gordon Cook

Clinical Director and Oncology Theme Lead

Share

Facebook
Twitter
LinkedIn